The Effects of Press Needle on Immune Function and Quality of Life Among Female Breast Cancer Patients After Radical Mastectomy: Study Protocol for a Randomised Controlled Trial

Ying Gao, Yao Wang, Hongchu Chen, Ran Yan, Tao Liu, Zhuohong Li, Jinhao ZengResearch 2021 · DOI

Abstract

Radical mastectomy is a primary treatment for breast cancer, but the procedure often leads to the suppression of cellular immune function, which can negatively impact a patient's quality of life (QOL) and increase the risk of postoperative complications. This protocol outlines a single-center, randomized, single-blinded trial designed to evaluate whether "press needles"—a specialized form of sustained acupuncture—can effectively modulate immune function and improve QOL in female patients following surgery.

Introduction: The Challenge of Post-Surgical Immunosuppression

While radical mastectomy is essential for many breast cancer patients, the physiological stress of surgery and anesthesia often results in significant immunosuppression. Specifically, levels of T-cells and natural killer (NK) cells frequently drop, potentially allowing circulating tumor cells to survive and increasing the risk of infections, anxiety, and insomnia.

Traditional pharmacological treatments for immunosuppression can carry adverse side effects. Acupuncture has shown potential in modulating immune responses, but standard sessions are often too brief to provide sustained benefits. This study investigates "press needles" as a non-pharmacological alternative that offers continuous stimulation to support the recovery trajectory of breast cancer survivors.

Methodology and Study Design

The study is a randomized, single-blinded, sham-controlled trial involving 78 female patients aged 18–80. Participants are randomized in a 1:1 ratio into either the press needle group or a sham control group.

  • The Intervention: The experimental group receives Japanese Seirin Pyonex press needles (0.2×1.5 mm) at six specific acupoints, including Zhongwan and Zusanli. These tiny, thumbtack-like needles remain embedded for 24 hours. Patients are instructed to manually press the needles for one minute every four hours to maintain stimulation.
  • The Control: The control group receives a sham press needle—a non-invasive device that mimics the sensation of the adhesive without penetrating the skin.
  • Blinding: To minimize bias, patients, outcome assessors, and statisticians are blinded to the group allocation.

Study Schedule

The trial consists of an enrollment phase, a two-week treatment phase (five sessions per week), and a two-week follow-up period. The schedule of assessments is detailed in the figure below.

Schedule of enrollment, interventions, and assessments according to the SPIRIT guidelines.

Outcomes and Metrics

The researchers aim to collect data on both physiological and psychological recovery markers:

  • Primary Metrics: Peripheral blood T-lymphocyte subsets (CD3+, CD4+, CD8+, and the CD4+/CD8+ ratio) measured via flow cytometry.
  • Secondary Metrics: Quality of life evaluated through the Karnofsky Performance Scale (KPS) and the EORTC QLQ-C30 questionnaire.

Discussion: The "Dose-Response" of Acupuncture

A key innovation of this protocol is the use of press needles to provide sustained stimulation. Unlike traditional acupuncture, which typically lasts 30 minutes, press needles remain in place for a full day. This increased "dose" of stimulation may be more effective at "untwisting" the relationship between surgical stress and cancer progression by bolstering T-cell-mediated immune responses. Furthermore, the requirement for patients to manually press the needles introduces an element of patient-led therapy that may offer additional psychological benefits.

Limitations and Future Directions

As a single-center trial based in Chengdu, China, the results may require broader multi-center validation to ensure generalizability. Additionally, while the study is rigorously blinded for assessors and patients, it is impossible to blind the acupuncturist performing the procedure. Future research will be needed to determine if the short-term immune boosts observed in this 4-week window translate into long-term improvements in cancer recurrence rates or overall mortality.

Conclusion

This study protocol provides a rigorous framework for evaluating a low-risk, non-pharmacological intervention for post-surgical breast cancer care. If successful, press needles could become a standard supportive therapy to help patients recover their immune function and improve their overall quality of life following radical mastectomy.

Summary updated

Abstract

Abstract BackgroundRadical mastectomy may lead to suppression of cellular immune function in patients with malignant tumors, and affect the quality of life (QOL) of patients. Immune suppression is a common cause of complications and adverse reactions in adjuvant therapy after radical mastectomy of breast cancer. Currently, there are few proven effective treatments for immune suppression. Therefore, it’s necessary to develop a new treatment method. Press needle is widely used in clinical practice. However, there have been relatively few studies that evaluate the effects of press needle on postoperative immune function. The aim of the present study is to assess the effects of press needle on immune function and QOL in female breast cancer patients undergoing radical mastectomy.MethodsThis study will be a single-center, randomized and single-blinded trial. 78 eligible patients will be randomized in a ratio of 1:1 to the press needle group or the sham press needle group. During the treatment phase, patients will undergo five times weekly of verum press needle or sham press needle for 2 weeks, and then they will be followed-up for 2 weeks. The primary outcome measures will be the peripheral blood levels of CD8+, CD4+, CD3+, and CD4+/CD8+ T cells. The secondary outcome measures will be the changes of patients’ QOL, evaluated by the Karnofsky Performance Scale (KPS) score and the EORTC core quality of life questionnaire (EORTC QLQ-C30). Safety and adverse events will be assessed at each visit. DiscussionThe results of this on-going study will provide clinical evidence for the effects and safety of press needle on immune function and QOL in patients after breast cancer resection compared with sham press needle.Trial registrationChinese Clinical Trial Registry, ChiCTR2000040100. Registered on 21 November 2020.
BibTeX
@inproceedings{gao2021effects,
  author = {Ying Gao and Yao Wang and Hongchu Chen and Ran Yan and Tao Liu and Zhuohong Li and Jinhao Zeng},
  title = {{The Effects of Press Needle on Immune Function and Quality of Life Among Female Breast Cancer Patients After Radical Mastectomy: Study Protocol for a Randomised Controlled Trial}},
  booktitle = {Research},
  year = {2021},
  doi = {10.21203/rs.3.rs-757641/v1},
}
Figure